Page last updated: 2024-10-28

hydroxychloroquine and Undiagnosed Diseases

hydroxychloroquine has been researched along with Undiagnosed Diseases in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Undiagnosed Diseases: Rare and common diseases lacking a diagnosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gochuico, BR1
Ziegler, SG1
Ten, NS1
Balanda, NJ1
Mason, CE1
Zumbo, P1
Evans, CA1
Van Waes, C1
Gahl, WA1
Malicdan, MCV1

Other Studies

1 other study available for hydroxychloroquine and Undiagnosed Diseases

ArticleYear
A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease.
    Translational research : the journal of laboratory and clinical medicine, 2020, Volume: 215

    Topics: Adolescent; Bronchoalveolar Lavage Fluid; Disease Progression; Female; Fibroblasts; Fibrosis; Gene E

2020